designed to determine the effects of early splenectomy on the duration and quality of survival in patients with chronic granulocytic leukaemia. We agree with the authors' view that previous splenectomy increases survival after the occurrence of acute transformation. One of our splenectomized patients lived 14 months after the onset of acute transformation; constitutional synmptoms, anaemia, and thrombocytopenia were notably less troublesome, and transfusion requirements were smaller than is usual at this stage of the disease in nonsplenectomized patients Dr. Schwarzenberg and his colleagues claim that leucocyte transfusions from patients with chronic granulocytic leukaemia are of "immense value" in treating septicaemia complicating neutropenia. This may well be true, but their results-a 52% cure rate for infections-are not superior to those obtained with antibiotic therapy alone (see table) .
Since the results of antibiotic therapy still leave much to be desired, it can be hoped 
